Hiroshi Yatsuhashi

8PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersHaematologyRespiratory diseasesPacific Peoples life courseMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 27, 2026
On-Treatment Reassessment of Type IV Collagen 7S and M2BPGi-Qt Improves Long-Term Hepatocellular Carcinoma Risk Stratification in Chronic Hepatitis B.

|Feb 26, 2026
Incidence and Characteristics of HBV Reactivation-Related Events Following HBsAg Seroclearance: Long-Term Follow-up of a Population-Based Cohort in Japan.

Kazumi Yamasaki, Satoshi Shirahama, Takahiro Yasaka

|Feb 09, 2026
Post-to Pretreatment Ratio of Serum CXCL10 Level Predicts Short-Term Liver Function Outcome in Compensated and Decompensated Cirrhotic Patients Due to Chronic Hepatitis C Virus Infection After Direct-Acting Antiviral Therapy.

Takanori Suzuki, Kentaro Matsuura, Yuki Tahata

|Sep 18, 2025
Serum Growth Differentiation Factor 15 Can Be a Novel Biomarker to Predict the Prognosis of Patients With Hepatitis C Virus Cirrhosis After Virus Elimination.

Yuta Myojin, Hayato Hikita, Yuki Tahata

|Oct 29, 2024
Factors involved in gastroesophageal varix-related events in patients with hepatitis C virus-related compensated and decompensated cirrhosis after direct-acting antiviral therapy.

Yuki Tahata, Hayato Hikita, Satoshi Mochida

|Oct 13, 2022
Health state utilities of patients with hepatitis B and C and hepatitis-related conditions in Japan.

Hiroki Sugimori, Maki Hirao, Ataru Igarashi

Pageof 2

Frequent Collaborators

3 joint publications

Yasunari Nakamoto

3 joint publications

Tetsuo Takehara

3 joint publications

Takahiro Kodama

3 joint publications

Taro Takami